NO20073610L - Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase - Google Patents
Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenaseInfo
- Publication number
- NO20073610L NO20073610L NO20073610A NO20073610A NO20073610L NO 20073610 L NO20073610 L NO 20073610L NO 20073610 A NO20073610 A NO 20073610A NO 20073610 A NO20073610 A NO 20073610A NO 20073610 L NO20073610 L NO 20073610L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- hydroxysteroid dehydrogenase
- thiophenpyrimidinone
- inhibitors
- newly substituted
- Prior art date
Links
- 108010070743 3(or 17)-beta-hydroxysteroid dehydrogenase Proteins 0.000 title abstract 2
- 102100034067 Dehydrogenase/reductase SDR family member 11 Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 230000001419 dependent effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 239000003270 steroid hormone Substances 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2004/053424 WO2006063615A1 (fr) | 2004-12-13 | 2004-12-13 | NOUVEAUX DÉRIVÉS SUBSTITUÉS DE THIOPHÈNEPYRIMIDINONE EN TANT QU'INHIBITEURS DE LA 17β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073610L true NO20073610L (no) | 2007-09-12 |
Family
ID=34959788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073610A NO20073610L (no) | 2004-12-13 | 2007-07-12 | Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1828197B1 (fr) |
| JP (1) | JP4686549B2 (fr) |
| CN (1) | CN101087793B (fr) |
| AT (1) | ATE431351T1 (fr) |
| AU (1) | AU2004325692B2 (fr) |
| BR (1) | BRPI0419229A (fr) |
| CA (1) | CA2590233A1 (fr) |
| DE (1) | DE602004021145D1 (fr) |
| ES (1) | ES2327240T3 (fr) |
| MX (1) | MX2007007051A (fr) |
| NO (1) | NO20073610L (fr) |
| PL (1) | PL1828197T3 (fr) |
| WO (1) | WO2006063615A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
| TW201520219A (zh) * | 2013-03-12 | 2015-06-01 | Lilly Co Eli | 咪唑並吡啶化合物 |
| BR112016015578A2 (pt) | 2014-01-03 | 2017-08-08 | Elexopharm Gmbh | Inibidores de 17beta-hidroxiesteroide desidrogenases tipo 1 e tipo 2 |
| CN120114459B (zh) * | 2025-05-14 | 2025-07-29 | 南京工业大学 | 苯并呋喃嘧啶酮或苯并噻吩嘧啶酮类化合物的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054656A (en) * | 1975-09-10 | 1977-10-18 | Mead Johnson & Company | Thieno[2,3-d]pyrimidine antiallergic agents |
| JPS62132884A (ja) * | 1985-12-05 | 1987-06-16 | Mitsubishi Chem Ind Ltd | ２−ベンジルチエノ〔２，３−ｄ〕ピリミジン−４（３Ｈ）−オン誘導体 |
| WO1989008113A1 (fr) * | 1988-03-02 | 1989-09-08 | Yoshitomi Pharmaceutical Industries, Ltd. | COMPOSES DE 3,4-DIHYDROTHIENO[2,3-d]PYRIMIDINE ET LEURS APPLICATIONS PHARMACOLOGIQUES |
| US5597823A (en) * | 1995-01-27 | 1997-01-28 | Abbott Laboratories | Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists |
| FI20030393A7 (fi) * | 2003-03-14 | 2004-09-15 | Molekyyliendokrinologian Tutkimusyksikkoe | Menetelmiä, joilla voidaan ennustaa rintasyövän kehistyskulku ja yhdisteitä, joita voidaan käyttää sen ehkäisemiseksi tai hoitamiseksi |
| US7465739B2 (en) * | 2003-06-10 | 2008-12-16 | Solvay Pharmaceuticals B.V. | Compounds and their use in therapy |
| US7754709B2 (en) * | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
-
2004
- 2004-12-13 CA CA002590233A patent/CA2590233A1/fr not_active Abandoned
- 2004-12-13 WO PCT/EP2004/053424 patent/WO2006063615A1/fr not_active Ceased
- 2004-12-13 EP EP04804787A patent/EP1828197B1/fr not_active Expired - Lifetime
- 2004-12-13 ES ES04804787T patent/ES2327240T3/es not_active Expired - Lifetime
- 2004-12-13 BR BRPI0419229-0A patent/BRPI0419229A/pt not_active IP Right Cessation
- 2004-12-13 JP JP2007545846A patent/JP4686549B2/ja not_active Expired - Fee Related
- 2004-12-13 DE DE602004021145T patent/DE602004021145D1/de not_active Expired - Lifetime
- 2004-12-13 AU AU2004325692A patent/AU2004325692B2/en not_active Expired - Fee Related
- 2004-12-13 AT AT04804787T patent/ATE431351T1/de not_active IP Right Cessation
- 2004-12-13 MX MX2007007051A patent/MX2007007051A/es active IP Right Grant
- 2004-12-13 CN CN200480044596XA patent/CN101087793B/zh not_active Expired - Fee Related
- 2004-12-13 PL PL04804787T patent/PL1828197T3/pl unknown
-
2007
- 2007-07-12 NO NO20073610A patent/NO20073610L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0419229A (pt) | 2007-12-18 |
| JP2008523117A (ja) | 2008-07-03 |
| DE602004021145D1 (de) | 2009-06-25 |
| AU2004325692A1 (en) | 2006-06-22 |
| CA2590233A1 (fr) | 2006-06-22 |
| AU2004325692B2 (en) | 2012-01-19 |
| EP1828197A1 (fr) | 2007-09-05 |
| PL1828197T3 (pl) | 2009-11-30 |
| CN101087793A (zh) | 2007-12-12 |
| CN101087793B (zh) | 2011-09-07 |
| ES2327240T3 (es) | 2009-10-27 |
| JP4686549B2 (ja) | 2011-05-25 |
| MX2007007051A (es) | 2007-06-26 |
| WO2006063615A1 (fr) | 2006-06-22 |
| EP1828197B1 (fr) | 2009-05-13 |
| ATE431351T1 (de) | 2009-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200509937A (en) | Novel compounds and their use in therapy | |
| WO2008034796A3 (fr) | Triazoles thérapeutiquement actives et leur utilisation | |
| TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| WO2006023544A3 (fr) | Applications therapeutiques d'inhibiteurs de rtp801 | |
| MXPA05013224A (es) | Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas. | |
| WO2007061661A3 (fr) | Inhibiteurs de la 11-beta-hydroxy steroide deshydrogenase de type 1 | |
| NO20076616L (no) | 17beta-HSD1- og STS-inhibitorer | |
| EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
| TNSN07161A1 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| DK1809280T3 (da) | Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf | |
| WO2007141796A3 (fr) | Utilisations thérapeutiques d'inhibiteurs de rtp801l | |
| TW200806325A (en) | Therapeutic uses of inhibitors of RTP801 | |
| WO2005084654A3 (fr) | Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs | |
| WO2009009417A3 (fr) | Compositions pharmaceutiques et procédés pour prévenir, traiter ou inhiber des maladies, des troubles ou des affections inflammatoires cutanés et des maladies, des troubles ou des affections associés à un appauvrissement en collagène | |
| WO2006074265A3 (fr) | Therapie combinee et compositions pharmaceutiques utilisees dans le traitement des troubles inflammatoires | |
| BRPI0506970B8 (pt) | derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior | |
| WO2006023866A3 (fr) | Acides thiazolo-naphthyliques | |
| NO20073610L (no) | Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase | |
| MXPA05013226A (es) | Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas. | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| NO20071466L (no) | 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE | |
| DK1784173T3 (da) | Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater | |
| WO2003094967A3 (fr) | Nouvelle combinaison destinee au traitement des troubles des voies aeriennes | |
| EP1597234A4 (fr) | Nouveaux composes | |
| TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |